These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers. Foretová L, Navrátilová M, Svoboda M, Házová J, Vašíčková P, Sťahlová EH, Fabian P, Schneiderová M, Macháčková E. Klin Onkol; 2019 Dec; 32(Supplementum2):118-122. PubMed ID: 31409087 [Abstract] [Full Text] [Related]
8. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. Marušić Z, Buljan M, Busam KJ. J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915 [Abstract] [Full Text] [Related]
14. Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations. Mochel MC, Piris A, Nose V, Hoang MP. Am J Clin Pathol; 2015 Jun 15; 143(6):901-4. PubMed ID: 25972334 [Abstract] [Full Text] [Related]
15. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist. Martorano LM, Winkelmann RR, Cebulla CM, Abdel-Rahman MH, Campbell SM. Int J Dermatol; 2014 Jun 15; 53(6):657-63. PubMed ID: 24697775 [Abstract] [Full Text] [Related]
16. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Shah AA, Bourne TD, Murali R. Pathology; 2013 Dec 15; 45(7):651-6. PubMed ID: 24247622 [Abstract] [Full Text] [Related]